Table 3 Multiple linear regression analysis of influenza viral clearance
Variables | Partial regression coefficienta | SE | t | p | VIF |
|---|---|---|---|---|---|
Type | 1.056 | ||||
Influenza A | Reference | NA | NA | NA | |
Influenza B | – 0.134 | 0.044 | – 3.067 | 0.002 | |
Age group | 1.194 | ||||
0–5 years | Reference | NA | NA | NA | |
6–18 years | 0.155 | 0.052 | 2.985 | 0.003 | |
≥ 19 years | 0.170 | 0.071 | 2.405 | 0.016 | |
Treatment | 1.234 | ||||
Baloxavir | Reference | NA | NA | NA | |
Laninamivir | – 0.167 | 0.058 | – 2.883 | 0.004 | |
Oseltamivir | – 0.154 | 0.041 | – 3.777 | < 0.001 | |
Zanamivir | – 0.075 | 0.064 | –1.171 | 0.242 | |
Vaccination status | 1.053 | ||||
Unvaccinated | Reference | NA | NA | NA | |
Vaccinated | 0.004 | 0.035 | 0.103 | 0.918 | |
PA variants | 1.072 | ||||
No | Reference | NA | NA | NA | |
Yes | – 0.468 | 0.094 | – 4.965 | < 0.001 | |
Interval time from onset to first visit | 0.026 | 0.026 | 0.979 | 0.328 | 1.009 |